Will BlueBird Bio's gene therapy for sickle cell disease receive Medicare coverage by the end of 2024?

Will BlueBird Bio's gene therapy for sickle cell disease be administered to more than 100 patients by the end of Q1 2025?

Will any major insurance company announce coverage for BlueBird Bio's gene therapy for sickle cell disease by the end of 2024?

Which entity will be the first to announce coverage for BlueBird Bio's gene therapy for sickle cell disease?

What will be the average cost of BlueBird Bio's gene therapy for sickle cell disease for patients after insurance coverage?

Which of the following will be the biggest barrier to the widespread adoption of BlueBird Bio's gene therapy for sickle cell disease?